US Stock MarketDetailed Quotes
BJDX Bluejay Diagnostics
- 3.7490
- +0.2290+6.51%
Trading Nov 25 14:47 ET
2.07MMarket Cap-4P/E (TTM)
3.8206High3.4000Low38.75KVolume3.5200Open3.5200Pre Close138.60KTurnover7.02%Turnover RatioLossP/E (Static)552.85KShares1564.000052wk High0.29P/B2.07MFloat Cap3.030052wk Low--Dividend TTM551.75KShs Float50000.0000Historical High--Div YieldTTM11.95%Amplitude3.0300Historical Low3.5770Avg Price1Lot Size
About Bluejay Diagnostics Company
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Company Profile
SymbolBJDX
Company NameBluejay Diagnostics
Listing DateNov 10, 2021
Issue Price10.00
Founded2015
CEOMr. Neil Dey
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address360 Massachusetts Avenue,Suite 203
CityActon
ProvinceMassachusetts
CountryUnited States of America
Zip Code01720
Phone1-978-631-4884
Websitehttp://www.bluejaydx.com
Company Executives
- Name
- Position
- Salary
- Neil Dey
- Principal Financial and Accounting Officer, President, Chief Executive Officer and Director
- 292.15K
- Dr. Jason Cook
- Chief Technology Officer
- 240.29K
- Douglas C. Wurth
- Chairman of the Board
- 109.60K
- Svetlana Dey
- Director
- 62.10K
- Fred S. Zeidman
- Independent Director
- 82.10K
- Donald R. Chase
- Independent Director
- 97.10K
- Gary Gemignani
- Independent Director
- 89.60K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data